BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16625449)

  • 1. [Effects of bisphosphonates in arthroplasty].
    Brankamp J; Eberhardt C; Landgräber S; von Knoch M; Saxler G; Löer F; Kurth AA
    Z Orthop Ihre Grenzgeb; 2006; 144(2):187-91. PubMed ID: 16625449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of action of the bisphosphonates.
    Fleisch H
    Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bisphosphonates in the treatment of multiple myeloma].
    Stajszczyk M
    Przegl Lek; 2002; 59(1):37-42. PubMed ID: 12108045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats.
    Astrand J; Aspenberg P
    Acta Orthop Scand; 2002 Jan; 73(1):24-30. PubMed ID: 11928907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New results from the use of bisphosphonates in cancer patients.
    Coleman R; Gnant M
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
    Chapurlat R; Meunier PJ
    Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bisphosphonates, their mechanism of action and properties useful in the therapy of metabolic bone diseases].
    Fojtík Z; Kandusová M
    Vnitr Lek; 1997 Apr; 43(4):234-7. PubMed ID: 9601843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption.
    Alvarez E; Westmore M; Galvin RJ; Clapp CL; Considine EL; Smith SJ; Keyes K; Iversen PW; Delafuente DM; Sulaimon S; Zambrano C; Ma L; Sato M; Martin TJ; Teicher BA; Galbreath EJ
    Clin Cancer Res; 2003 Nov; 9(15):5705-13. PubMed ID: 14654555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictions on preserving bone mass in knee arthroplasty with bisphosphonates.
    Nyman JS; Rodrigo JJ; Hazelwood SJ; Yeh OC; Martin RB
    J Arthroplasty; 2006 Jan; 21(1):106-13. PubMed ID: 16446194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bisphosphonates in pharmacotherapy of bone diseases].
    Iur'ieva EA; Matkovskaia TA; Elagina IA; Stoliarov IuIu
    Eksp Klin Farmakol; 2000; 63(3):74-9. PubMed ID: 10934603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental basis for the use of bisphosphonates in Paget's disease of bone.
    Fleisch H
    Clin Orthop Relat Res; 1987 Apr; (217):72-8. PubMed ID: 3549097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bisphosphonates: indications in bone diseases other than osteoporosis].
    Abdelmoula LC; Ben M'barek R; Ben Hadj Yahia C; Tekaya R; Testouri N; Chaabouni L; Zouari R
    Tunis Med; 2011 Jun; 89(6):511-6. PubMed ID: 21681711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis.
    Bhandari M; Bajammal S; Guyatt GH; Griffith L; Busse JW; Schünemann H; Einhorn TA
    J Bone Joint Surg Am; 2005 Feb; 87(2):293-301. PubMed ID: 15687150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapies of bone graft around non-cemented experimental orthopedic implants stereological methods and experiments in dogs.
    Baas J
    Acta Orthop Suppl; 2008 Aug; 79(330):1-43. PubMed ID: 19065776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of bisphosphonates for periodontitis].
    Shinoda H; Takeyama S
    Clin Calcium; 2006 Feb; 16(2):341- 47. PubMed ID: 16465039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates in orthopedic applications.
    Wilkinson JM; Little DG
    Bone; 2011 Jul; 49(1):95-102. PubMed ID: 21256254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates in the treatment of disorders of mineral metabolism.
    Singer FR; Minoofar PN
    Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates in multiple myeloma.
    Apperley JF; Croucher PI
    Pathol Biol (Paris); 1999 Feb; 47(2):178-81. PubMed ID: 10192885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of risedronate on bone metabolism after total hip arthroplasty: a prospective randomised study.
    Kinov P; Tivchev P; Doukova P; Leithner A
    Acta Orthop Belg; 2006 Jan; 72(1):44-50. PubMed ID: 16570894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.
    Hodsman A; Adachi J; Olszynski W
    CMAJ; 1996 Oct; 155(7):945-8. PubMed ID: 8837544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.